# covid19-mabs-rwe
The analytic pipeline was developed as part of the Real World Evidence to Accelerate COVID-19 Therapeutics project to conduct a real-world observational study of the safety and effectiveness of Monoclonal Antibodies (mAbs) to fight SARS-CoV-2.
